Download

NEW YORK--(BUSINESS WIRE)--Pfizer Inc announced today that Greg Simon has joined the company as
Senior Vice President, Worldwide Policy. He comes to Pfizer from the
presidency of FasterCures, where he led efforts to reform
policies governing biopharmaceutical discovery and development, with the
goal of bringing a greater number of lifesaving medicines more quickly
to doctors and patients.

“Greg and his record of leadership are well-known to us at Pfizer,” said
Jeffrey B. Kindler, chairman and chief executive officer of Pfizer. “He
shares our commitment to good health and great science, and to shaping
policies that unleash the power of innovation so that more people can
gain greater access to safe and effective new treatments. He joins us at
a pivotal time as we advocate comprehensive health care reform in the
United States; move into new therapies, such as vaccines; and bring
forward a host of new treatments, including many for cancer, to clinical
trials.”

He will report to Sandy Beaty, who is currently responsible for policy
and government relations at Pfizer. Mr. Simon will assume responsibility
for counsel and action on health care, science and technology policy
issues.

“In my six years at FasterCures, I came to realize that the
future of health, both in the U.S. and around the world, depends on all
sectors of society — government, industry, academia and nonprofits —
working together,” said Mr. Simon. “Having worked in government and the
nonprofit sector, I believe I will bring a unique perspective to Pfizer
as it shapes its global health policy for the future. I am thrilled to
work with the excellent team at Pfizer to address the most important
issue of our time —bringing better health care and health cures
to people everywhere.”

Mr. Simon joined FasterCures, an independent, nonpartisan
organization, in 2003. A center of the California-based Milken
Institute, FasterCures proposes and pursues improvements in the
biomedical research and development process. Last October, Mr. Simon was
named by the journal Nature Medicine as one of “Ten People to
Watch” in health care policy, noting that he was among “a handful of
influential people who quietly keep the wheels of biomedical science
turning.”

Michael Milken, Chairman of the Milken Institute, said, “Under Greg’s
leadership, FasterCures has grown from an innovative idea to an
effective reality. He and his team have begun to change the process of
medical research, an effort that will accelerate improved treatment
outcomes for people everywhere and will produce more lifesaving cures.”

Mr. Simon was chief domestic policy advisor to Vice President Al Gore
from 1993 to 1997. In that capacity, he oversaw a number of key
initiatives, including programs at the National Institutes of Health,
the National Cancer Institute, the Food and Drug Administration, and the
Human Genome Project. He was also instrumental in crafting the
regulatory framework that is now the foundation for the biotechnology
industry. From 1985 to 1991, Mr. Simon was Staff Director of the
Investigations and Oversight Subcommittee of the U.S. House of
Representatives Committee on Science, Space and Technology. He served as
Sen. Gore’s Legislative Director from 1991 to 1993.

He received his law degree from the University of Washington in 1983. He
has a B.A. in history from the University of Arkansas.

About Pfizer Inc

Founded in 1849, Pfizer is the world's premier biopharmaceutical company
taking new approaches to better health. Pfizer discovers, develops,
manufactures and delivers quality, safe and effective prescription
medicines to treat and help prevent disease for both people and animals.
Pfizer also partners with healthcare providers, governments and local
communities around the world to expand access to medicines and provide
better-quality health care and health system support. At Pfizer, more
than 80,000 colleagues in more than 90 countries work every day to help
people stay happier and healthier longer and to reduce the human and
economic burden of disease worldwide.